Bachmann Christian J, Czwikla Jonas, Jacobs Hannes, Fegert Jörg M, Hoffmann Falk
Klinik für Kinder- und Jugendpsychiatrie/Psychotherapie, Universitätsklinikum Ulm.
Abteilung Ambulante Versorgung und Pharmakoepidemiologie, Department für Versorgungsforschung, Carl von Ossietzky Universität Oldenburg.
Psychiatr Prax. 2021 Sep;48(6):316-323. doi: 10.1055/a-1347-5410. Epub 2021 Jan 20.
To provide German data regarding prevalence and treatment (pharmacotherapy, psychotherapy) for individuals with PTSD.
Based on BARMER health insurance data, the administrative prevalence of PTSD (ICD-10: F43.1), psychiatric comorbidity, psychotherapy and pharmacotherapy were estimated. Additionally, prevalence trends for years 2008 vs. 2017 were computed.
In 2017, the overall PTSD prevalence was 0.7 % (females: 0.9 %, males: 0.4 %), whereas in 2008 it was 0.3 %. 74.4 % of all PTSD cases received psychotherapy, 43.6 % were prescribed an antidepressant (first choice: venlafaxine), and 14.4 % were prescribed an antipsychotic (first choice: quetiapine).
Within the studied period, the administrative prevalence of PTSD has more than doubled. Still, the prevalence rate found in our study is lower than figures from epidemiological studies, thus indicating room for improvement in diagnosing PTSD.
提供有关创伤后应激障碍（PTSD）患者患病率及治疗（药物治疗、心理治疗）情况的德国数据。
基于BARMER医疗保险数据，估算PTSD（国际疾病分类第十版：F43.1）的管理患病率、精神共病情况、心理治疗及药物治疗情况。此外，计算了2008年与2017年的患病率趋势。
2017年，PTSD总体患病率为0.7%（女性：0.9%，男性：0.4%），而2008年为0.3%。所有PTSD病例中，74.4%接受了心理治疗，43.6%被开具了抗抑郁药（首选：文拉法辛），14.4%被开具了抗精神病药（首选：喹硫平）。
在研究期间，PTSD的管理患病率增加了一倍多。然而，我们研究中发现的患病率低于流行病学研究数据，这表明在PTSD诊断方面仍有改进空间。
